50
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Gender-specific association of functional prodynorphin 68 bp repeats with cannabis exposure in an African American cohort

, &
Pages 1025-1034 | Published online: 16 Apr 2018

References

  • KerridgeBTPickeringRChouPSahaTDHasinDSDSM-5 cannabis use disorder in the national epidemiologic survey on alcohol and related conditions-III: gender-specific profilesAddict Behav201876526028755613
  • BlancoCHasinDSWallMMCannabis use and risk of psychiatric disorders: prospective evidence from a us national longitudinal studyJAMA Psychiatry201673438839526886046
  • VolkowNDSwansonJMEvinsAEEffects of cannabis use on human behavior, including cognition, motivation, and psychosis: a reviewJAMA Psychiatry201673329229726842658
  • GrimTWMoralesAJGonekMMStratification of cannabinoid 1 receptor (CB1R) agonist efficacy: manipulation of CB1R density through use of transgenic mice reveals congruence between in vivo and in vitro assaysJ Pharmacol Exp Ther2016359232933927535976
  • KatiaBInteractions of the opioid and cannabinoid systems in reward: insights from knockout studiesFront Pharmacol20156625698968
  • ZimmerAValjentEKonigMAbsence of delta-9-tetrahydro-cannabinol dysphoric effects in dynorphin-deficient miceJ Neurosci200121239499950511717384
  • GhozlandSMatthesHWSimoninFFilliolDKiefferBLMaldonadoRMotivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptorsJ Neurosci20022231146115411826143
  • ReedBFangNMayer-BlackwellBChromatin alterations in response to forced swimming underlie increased prodynorphin transcriptionNeuroscience201222010911822698692
  • SpanglerRUnterwaldEMKreekMJ“Binge” cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamenBrain Res Mol Brain Res19931943233277694032
  • CarlezonWAJrBeguinCKnollATCohenBMKappa-opioid ligands in the study and treatment of mood disordersPharmacol Ther2009123333434319497337
  • ButelmanERYuferovVKreekMJKappa-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addictionTrends Neurosci2012351058759622709632
  • DaunaisJBRobertsDCMcGintyJFCocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatumNeuroreport1993455435468099817
  • Di ChiaraGImperatoAOpposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving ratsJ Pharmacol Exp Ther19882443106710802855239
  • ZhangYButelmanERSchlussmanSDHoAKreekMJEffect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J micePsychopharmacology (Berl)2004172442242914712335
  • HorikawaSTakaiTToyosatoMIsolation and structural organization of the human preproenkephalin B geneNature198330659436116146316163
  • WilliamsTJLaForgeKSGordonDProdynorphin gene promoter repeat associated with cocaine/alcohol codependenceAddict Biol2007123–449650217559549
  • ZimprichAKrausJWoltjeMMayerPRauchEHolltVAn allelic variation in the human prodynorphin gene promoter alters stimulus-induced expressionJ Neurochem200074247247710646497
  • BabbittCCSilvermanJSHaygoodRReiningaJMRockmanMVWrayGAMultiple functional variants in cis modulate PDYN expressionMol Biol Evol201027246547919910384
  • RouaultMNielsenDAHoAKreekMJYuferovVCell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activityAddict Biol201116233434620731629
  • YuferovVJiFNielsenDAA functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brainNeuropsychopharmacology20093451185119718923396
  • FangJYinLCaoSLiaoYXueCDye-sensitized Pt@Tio2 core-shell nanostructures for the efficient photocatalytic generation of hydrogenBeilstein J Nanotechnol2014536036424778960
  • LiuYKieslichCAMorikisDLiaoJEngineering pre-SUMO4 as efficient substrate of SENP2Protein Eng Des Sel201427411712624671712
  • DahlJPWellerAEKampmanKMConfirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependenceAm J Med Genet B Neuropsychiatr Genet2005139B110610816184603
  • WeiSGZhuYSLaiJHXueHXChaiZQLiSBAssociation between heroin dependence and prodynorphin gene polymorphismsBrain Res Bull2011853–423824221382455
  • RayRDoyleGACrowleyJJA functional prodynorphin promoter polymorphism and opioid dependencePsychiatr Genet200515429529816314761
  • NikoshkovADrakenbergKWangXHorvathMCKellerEHurdYLOpioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expressionProc Natl Acad Sci U S A2008105278679118184800
  • SloanMEGowinJLYanJSeverity of alcohol dependence is associated with the fatty acid amide hydrolase Pro129thr missense variantAddict Biol201823147448428150397
  • SavageJESawyersCRoberson-NayRHettemaJMThe genetics of anxiety-related negative valence system traitsAm J Med Genet B Neuropsychiatr Genet2017174215617727196537
  • LiangPWLiaoCYChuehCCAdditive enhanced crystallization of solution-processed perovskite for highly efficient planarheterojunction solar cellsAdv Mater201426223748375424634141
  • KelloggSHMcHughPFBellKThe Kreek-McHugh-Schluger-Kellogg Scale: a new, rapid method for quantifying substance abuse and its possible applicationsDrug Alcohol Depend200369213715012609695
  • CrystalHAHamonSRandesiMA C17t polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American womenAddict Biol201217118119121070507
  • ZhouZYuanQMashDCGoldmanDSubstance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcoholProc Natl Acad Sci U S A2011108166626663121464311
  • LevranORandesiMLiYDrug addiction and stress-response genetic variability: association study in African AmericansAnn Hum Genet201478429029824766650
  • BondCLaForgeKSTianMSingle-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addictionProc Natl Acad Sci U S A19989516960896139689128
  • FirstMBSpitzerRLGibbonMWilliamsJBWStructured Clinical Interview for DSM-IV-Tr Axis I Disorders, Research Version, Patient Edition (SCID-I/P; Version 20)New YorkBiometrics Research Department, New York State Psychiatric Institute2002
  • JacksonCBVaronJHoAMarksKMTalalAHKreekMJIdentification of substance use and dependence among patients with viral hepatitisDig Liver Dis201042965065620418192
  • TangYLKhouryLBradleyBGillespieCFResslerKJCubellsJFSubstance use disorders assessed using the Kreek-Mchugh-Schluger-Kellogg (KMSK) scale in an urban low-income and predominantly African American sample of primary care patientsAm J Addict201120329229921477058
  • FloryJDPytteCLHurdYFerrellREManuckSBAlcohol dependence, disinhibited behavior and variation in the prodynorphin geneBiol Psychol2011881515621736916
  • BehrendtSWittchenHUHoflerMLiebRBeesdoKTransitions from first substance use to substance use disorders in adolescence: is early onset associated with a rapid escalation?Drug Alcohol Depend2009991–3687818768267
  • ChenCYStorrCLAnthonyJCEarly-onset drug use and risk for drug dependence problemsAddict Behav200934331932219022584
  • KreekMJNielsenDAButelmanERLaForgeKSGenetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addictionNat Neurosci20058111450145716251987
  • AgrawalALynskeyMTCandidate genes for cannabis use disorders: findings, challenges and directionsAddiction2009104451853219335651
  • EgervariGJutras-AswadDLandryJA functional 3′UTR polymorphism (rs2235749) of prodynorphin alters microrna-365 binding in ventral striatonigral neurons to influence novelty seeking and positive reward traitsNeuropsychopharmacology201641102512252027074815
  • SpanagelRHerzAShippenbergTSOpposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathwayProc Natl Acad Sci U S A1992896204620501347943
  • ZernigGPinheiroBSDyadic social interaction inhibits cocaine-conditioned place preference and the associated activation of the accumbens corridorBehav Pharmacol201526658059426221832
  • AdamantidisARTsaiHCBoutrelBOptogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behaviorJ Neurosci20113130108291083521795535
  • KnollATMuschampJWSillivanSEKappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in ratsBiol Psychiatry201170542543321531393
  • TandaGPontieriFEDi ChiaraGCannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanismScience19972765321204820509197269
  • ChartoffEHMavrikakiMSex differences in kappa opioid receptor function and their potential impact on addictionFront Neurosci2015946626733781
  • McCabeSEWestBTJutkiewiczEMBoydCJMultiple DSM-5 substance use disorders: a national study of us adultsHum Psychopharmacol Epub2017727
  • RubinoTViganoDRealiniNChronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlatesNeuropsychopharmacology200833112760277118172430